The Food and Drug Administration (FDA) has approved TecentriqHybreza ™ (atezolizumab and hyaluronidase-tqjs) for subcutaneous (SC) injection, for all the approved adult indications of intravenous ...
TecentriqHybreza provides patients and physicians with greater flexibility of treatment options while showing safety and efficacy consistent with intravenous (IV) Tecentriq – – New ...
Some results have been hidden because they may be inaccessible to you